Home›People›Bryan Kim
BK

Bryan Kim

Co-Founder and CEO/President, director at Verismo Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing May 20, 2026·Suggest an edit

About Bryan Kim

Bryan Kim is a co-founder and ceo/president, director at Verismo Therapeutics.

Bryan Kim first appears on SEC filings in 2021.

Experience

This experience comes from Bryan Kim's profile and from SEC filings. For roles taken from filings, the years are when the filings name Bryan Kim in the role, so the role may have started earlier or lasted longer.

HLB innoVation Co.,Ltd Current
Co-CEO
2025 – Present
Verismo Therapeutics, Inc. Current
Co-Founder and CEO/President, director
CEO / co-founder (2021 – Present)
2021 – Present · Philadelphia, PA
Develops cell therapies for people with solid tumors and blood cancers.
Hyundai Pharm
Senior Advisor
2014 – 2021
Transcure Bio Ventures, Inc.
CEO / Founder
2013 – 2021
Cellecture
CEO
2016
Inovio Pharmaceuticals Inc.
Vice President
2009 – 2011
VGXI, Inc.
CEO / President
2008 – 2011
VGX International, Inc.
CEO / President
2005 – 2011
VGX Pharmaceuticals, Inc.
Vice President
2005 – 2009
University of Pennsylvania School of Dental Medicine
Clinical Associate Professor
1999 – 2005

Key Colleagues at Startups

The people Bryan Kim works with at each company, as listed on that company's latest Form D.

Verismo Therapeutics, Inc. · Form D, May 20, 2026
JY
Jong Yoon
Director
DK
Dong Kim
Director
YJ
Yang Jin
Director
GK
Gene Kim
Chief Financial Officer

Sources

  1. SECVerismo Therapeutics, Inc. Form D, filed May 20, 2026